Literature DB >> 24335298

Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.

Hye-Ra Lee1, Sultan Doğanay, Brian Chung, Zsolt Toth, Kevin Brulois, Stacy Lee, Zhansaya Kanketayeva, Pinghui Feng, Taekjip Ha, Jae U Jung.   

Abstract

Besides an essential transcriptional factor for B cell development and function, cellular interferon regulatory factor 4 (c-IRF4) directly regulates expression of the c-Myc gene, which is not only associated with various B cell lymphomas but also required for herpesvirus latency and pathogenesis. Kaposi's sarcoma-associated herpesvirus (KSHV), the etiological agent of Kaposi's sarcoma and primary effusion lymphoma, has developed a unique mechanism to deregulate host antiviral innate immunity and growth control by incorporating four viral homologs (vIRF1 to -4) of cellular IRFs into its genome. Previous studies have shown that several KSHV latent proteins, including vIRF3, vFLIP, and LANA, target the expression, function, and stability of c-Myc to establish and maintain viral latency. Here we report that the KSHV vIRF4 lytic protein robustly suppresses expression of c-IRF4 and c-Myc, reshaping host gene expression profiles to facilitate viral lytic replication. Genomewide gene expression analysis revealed that KSHV vIRF4 grossly affects host gene expression by upregulating and downregulating 118 genes and 166 genes, respectively, by at least 2-fold. Remarkably, vIRF4 suppressed c-Myc expression by 11-fold, which was directed primarily by the deregulation of c-IRF4 expression. Real-time quantitative PCR (RT-qPCR), single-molecule in situ hybridization, and chromatin immunoprecipitation assays showed that vIRF4 not only reduces c-IRF4 expression but also competes with c-IRF4 for binding to the specific promoter region of the c-Myc gene, resulting in drastic suppression of c-Myc expression. Consequently, the loss of vIRF4 function in the suppression of c-IRF4 and c-Myc expression ultimately led to a reduction of KSHV lytic replication capacity. These results indicate that the KSHV vIRF4 lytic protein comprehensively targets the expression and function of c-IRF4 to downregulate c-Myc expression, generating a favorable environment for viral lytic replication. Finally, this study further reinforces the important role of the c-Myc gene in KSHV lytic replication and latency.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24335298      PMCID: PMC3911525          DOI: 10.1128/JVI.02106-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.

Authors:  Adriana Forero; Patrick S Moore; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

3.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.

Authors:  N Dupin; T L Diss; P Kellam; M Tulliez; M Q Du; D Sicard; R A Weiss; P G Isaacson; C Boshoff
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

4.  The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.

Authors:  M Bemark; M S Neuberger
Journal:  Oncogene       Date:  2000-07-13       Impact factor: 9.867

5.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

6.  Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.

Authors:  T Yano; C A Sander; H M Clark; M V Dolezal; E S Jaffe; M Raffeld
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

7.  Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein.

Authors:  Hye-Ra Lee; Won-Chan Choi; Stacy Lee; Jungwon Hwang; Eunha Hwang; Koushik Guchhait; Juergen Haas; Zsolt Toth; Young Ho Jeon; Tae-Kwang Oh; Myung Hee Kim; Jae U Jung
Journal:  Nat Struct Mol Biol       Date:  2011-11-06       Impact factor: 15.369

8.  The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor.

Authors:  Kelly Hew; Sue-Li Dahlroth; Rajakannan Venkatachalam; Fariborz Nasertorabi; Bee Ting Lim; Tobias Cornvik; Pär Nordlund
Journal:  Nucleic Acids Res       Date:  2013-02-21       Impact factor: 16.971

9.  IRF4 is a suppressor of c-Myc induced B cell leukemia.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; James Eudy; Kay-Uwe Wagner; Shantaram S Joshi; Runqing Lu
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

10.  Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB.

Authors:  R J Grumont; S Gerondakis
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

View more
  19 in total

Review 1.  Novel functions of viral anti-apoptotic factors.

Authors:  Chengyu Liang; Byung-Ha Oh; Jae U Jung
Journal:  Nat Rev Microbiol       Date:  2014-11-03       Impact factor: 60.633

Review 2.  Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.

Authors:  Marni S Crow; Krystal K Lum; Xinlei Sheng; Bokai Song; Ileana M Cristea
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

3.  Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway.

Authors:  Gavin Golas; Seung Jin Jang; Nenavath Gopal Naik; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  Virology       Date:  2019-12-30       Impact factor: 3.616

4.  IRF4 and IRF8: Governing the virtues of B Lymphocytes.

Authors:  Vipul Shukla; Runqing Lu
Journal:  Front Biol (Beijing)       Date:  2014-08

5.  Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 4 (vIRF4) Perturbs the G1-S Cell Cycle Progression via Deregulation of the cyclin D1 Gene.

Authors:  Hye-Ra Lee; Jaba Mitra; Stacy Lee; Shou-Jiang Gao; Tae-Kwang Oh; Myung Hee Kim; Taekjip Ha; Jae U Jung
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

6.  Genome-Wide Mapping of the Binding Sites and Structural Analysis of Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 2 Reveal that It Is a DNA-Binding Transcription Factor.

Authors:  Haidai Hu; Jiazhen Dong; Deguang Liang; Zengqiang Gao; Lei Bai; Rui Sun; Hao Hu; Heng Zhang; Yuhui Dong; Ke Lan
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

7.  Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs.

Authors:  Angela Park; Soohwan Oh; Kyle L Jung; Un Yung Choi; Hye-Ra Lee; Michael G Rosenfeld; Jae U Jung
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

Review 8.  Immune control of oncogenic γ-herpesviruses.

Authors:  Jae Jung; Christian Münz
Journal:  Curr Opin Virol       Date:  2015-09-13       Impact factor: 7.090

Review 9.  Molecular biology of KSHV lytic reactivation.

Authors:  Pravinkumar Purushothaman; Timsy Uppal; Subhash C Verma
Journal:  Viruses       Date:  2015-01-14       Impact factor: 5.048

Review 10.  Metabolic Control by DNA Tumor Virus-Encoded Proteins.

Authors:  Martin A Prusinkiewicz; Joe S Mymryk
Journal:  Pathogens       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.